QIAGEN and Myriad Genetics Partner on Companion Diagnostics for Cancer
QIAGEN and Myriad Genetics announced a new master collaboration agreement to develop companion diagnostic tests in the field of cancer.
Read MorePosted by Andy Lundin | Oct 26, 2023 | Cancer, Company News |
QIAGEN and Myriad Genetics announced a new master collaboration agreement to develop companion diagnostic tests in the field of cancer.
Read MorePosted by Andy Lundin | Oct 24, 2023 | Digital Pathology |
Proscia earned ISO 27001 certification, demonstrating the company’s compliance with a well-known information security management standard.
Read MorePosted by Chris Wolski | Oct 19, 2023 | Compliance |
The FDA has issued proposed LDT rulemaking. Laboratories have an opportunity to make comments before it becomes official.
Read MorePosted by Chris Wolski | Oct 10, 2023 | Flu & Respiratory Infections |
A parallel test developed by Karius aims to improve treatment for serious diseases by diagnosing infections more rapidly and effectively.
Read MorePosted by Chris Wolski | Sep 26, 2023 | Sepsis |
Steripath delivers critical time savings for sepsis diagnosis, improving patient outcomes and providing cost efficiencies.
Read More